Similar articles for PMID: 9217996

Year	Number of Results
1992	1
1993	3
1994	4
1995	7
1996	17
1997	13
1998	17
1999	11
2000	10
2001	9
2002	7
2003	6
2004	8
2005	2
2007	1
2011	2
2013	1
2014	2
2016	2
2017	2
2018	1
2019	2
2020	1
2021	2
2022	1
2023	1
2024	0

1

Complementation group assignments in Fanconi anemia fibroblast cell lines from North America.

Jakobs PM, Fiddler-Odell E, Reifsteck C, Olson S, Moses RE, Grompe M. Jakobs PM, et al. Somat Cell Mol Genet. 1997 Jan;23(1):1-7. doi: 10.1007/BF02679950. Somat Cell Mol Genet. 1997. PMID: 9217996

2

Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.

Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, Altay C, Poole J, Stones D, Kwee ML, van Weel-Sipman M, Havenga C, Morgan N, de Winter J, Digweed M, Savoia A, Pronk J, de Ravel T, Jansen S, Joenje H, Gluckman E, Mathew CG. Faivre L, et al. Blood. 2000 Dec 15;96(13):4064-70. Blood. 2000. PMID: 11110674 Free article.

3

Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.

Yamashita T, Wu N, Kupfer G, Corless C, Joenje H, Grompe M, D'Andrea AD. Yamashita T, et al. Blood. 1996 May 15;87(10):4424-32. Blood. 1996. PMID: 8639804 Free article.

4

Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model.

Tomkins DJ, Care M, Carreau M, Buchwald M. Tomkins DJ, et al. Mutat Res. 1998 Jul;408(1):27-35. doi: 10.1016/s0921-8777(98)00015-9. Mutat Res. 1998. PMID: 9678061

5

Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.

Siddique MA, Nakanishi K, Taniguchi T, Grompe M, D'Andrea AD. Siddique MA, et al. Exp Hematol. 2001 Dec;29(12):1448-55. doi: 10.1016/s0301-472x(01)00754-8. Exp Hematol. 2001. PMID: 11750104 Free article.

6

A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.

Kupfer G, Naf D, Garcia-Higuera I, Wasik J, Cheng A, Yamashita T, Tipping A, Morgan N, Mathew CG, D'Andrea AD. Kupfer G, et al. Exp Hematol. 1999 Apr;27(4):587-93. doi: 10.1016/s0301-472x(99)00022-3. Exp Hematol. 1999. PMID: 10210316 Free article.

7

Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.

Yamashita T, Nakahata T. Yamashita T, et al. Int J Hematol. 2001 Jul;74(1):33-41. doi: 10.1007/BF02982547. Int J Hematol. 2001. PMID: 11530803 Review.

8

Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.

Adachi D, Oda T, Yagasaki H, Nakasato K, Taniguchi T, D'Andrea AD, Asano S, Yamashita T. Adachi D, et al. Hum Mol Genet. 2002 Dec 1;11(25):3125-34. doi: 10.1093/hmg/11.25.3125. Hum Mol Genet. 2002. PMID: 12444097

9

MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups.

Li Y, Youssoufian H. Li Y, et al. J Clin Invest. 1997 Dec 1;100(11):2873-80. doi: 10.1172/JCI119836. J Clin Invest. 1997. PMID: 9389754 Free PMC article.

10

Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.

Kruyt FA, Dijkmans LM, van den Berg TK, Joenje H. Kruyt FA, et al. Blood. 1996 Feb 1;87(3):938-48. Blood. 1996. PMID: 8562965 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

127 results

Results by year